Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Lein raises Funding after Successful Clinical Tests of Painless Diabetes Meter

11.01.2006


Lein Applied Diagnostics Ltd, a Berkshire-based company that is developing a revolutionary new product to measure blood glucose levels in people with diabetes, has successfully completed clinical tests of its advanced prototypes and secured further investment from Seven Spires Investments, a member of Thames Valley Investment Network (TVIN). The funding will enable Lein to accelerate the development programme for its non-invasive optical instrument.



Diabetes is a major problem, with 1.8 million sufferers in the UK and over 170m worldwide. The numbers are predicted to rise dramatically due to an ageing population and the general increase in obesity rates. People with Type 1 diabetes must measure their glucose levels four or five times a day in order to control their condition; they currently take a blood sample from a finger prick test, which is painful, inconvenient and can be unhygienic. As a result, some people do not test themselves as often as they should, increasing the likelihood of complications such as heart disease and blindness.

Lein’s patented blood glucose meter could transform the way people with diabetes test their blood glucose levels. In recent clinical tests, an advanced prototype of the instrument, which uses an innovative optical measurement technique to track the amount of glucose in the eye, produced well correlated readings of blood glucose levels when tested on volunteers with widely varying ages. Successful tests have also been performed on volunteers with contact lenses.


Dr Dan Daly, Director of Lein Applied Diagnostics, explained: “We are delighted with the excellent results from our clinical tests, and pleased that Seven Spires Investments have provided us with further investment, following on from the initial funding secured after we presented at a TVIN meeting. Having achieved our clinical and technical goals, we are now ready to accelerate our development programme.

We have grown from two to nine staff during the last year, and we are working closely with a range of expert partners including Sira, the University of Manchester and the Institute of Photonics at the University of Strathclyde which provide invaluable ophthalmic and optical support. I am confident that we will meet the challenging targets that we have set ourselves for the next year. Our ultimate aim is to produce a small, battery-powered device that can be carried around in a pocket or handbag.”

Eileen Modral, Manager of the TVIN Network said: “We congratulate Lein on their successful clinical tests and on securing further major funding from Seven Spires Investments, a longstanding member of the TVIN Network. By completely eliminating the need for finger prick tests, Lein’s instrument should improve the quality of life for millions of people. We believe that their innovative technology is going to cause significant disruption in the £2.6 billion self-testing market.”

TVIN is managed by Oxford Innovation Ltd (www.oxin.co.uk), the UK’s leading operator of innovation centre premises for start-up companies, and sponsored by the Thames Valley Economic Partnership, the South East England Development Agency and Business Link.

The next meeting of Thames Valley Investment Network is on 26 January 2006.

Margaret Henry | alfa
Further information:
http://www.oxin.co.uk
http://www.tvin.co.uk

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>